Utah Medical Products ROE 2006-2019 | UTMD
Current and historical return on equity (ROE) values for Utah Medical Products (UTMD) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Utah Medical Products ROE for the three months ending June 30, 2019 was 15.13%.
| Utah Medical Products ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2019-06-30 | $0.02B | $0.09B | 18.68% |
| 2019-03-31 | $0.02B | $0.09B | 19.26% |
| 2018-12-31 | $0.02B | $0.09B | 20.93% |
| 2018-09-30 | $0.01B | $0.09B | 14.41% |
| 2018-06-30 | $0.01B | $0.08B | 11.08% |
| 2018-03-31 | $0.01B | $0.08B | 11.29% |
| 2017-12-31 | $0.01B | $0.08B | 11.65% |
| 2017-09-30 | $0.02B | $0.08B | 20.00% |
| 2017-06-30 | $0.01B | $0.08B | 19.18% |
| 2017-03-31 | $0.01B | $0.07B | 18.18% |
| 2016-12-31 | $0.01B | $0.07B | 16.84% |
| 2016-09-30 | $0.01B | $0.07B | 16.78% |
| 2016-06-30 | $0.01B | $0.07B | 17.08% |
| 2016-03-31 | $0.01B | $0.07B | 17.27% |
| 2015-12-31 | $0.01B | $0.07B | 17.78% |
| 2015-09-30 | $0.01B | $0.07B | 18.11% |
| 2015-06-30 | $0.01B | $0.07B | 18.39% |
| 2015-03-31 | $0.01B | $0.06B | 18.60% |
| 2014-12-31 | $0.01B | $0.07B | 18.68% |
| 2014-09-30 | $0.01B | $0.06B | 18.97% |
| 2014-06-30 | $0.01B | $0.07B | 19.51% |
| 2014-03-31 | $0.01B | $0.06B | 20.51% |
| 2013-12-31 | $0.01B | $0.06B | 21.62% |
| 2013-09-30 | $0.01B | $0.06B | 20.75% |
| 2013-06-30 | $0.01B | $0.05B | 21.57% |
| 2013-03-31 | $0.01B | $0.05B | 20.30% |
| 2012-12-31 | $0.01B | $0.05B | 20.94% |
| 2012-09-30 | $0.01B | $0.05B | 22.10% |
| 2012-06-30 | $0.01B | $0.05B | 20.93% |
| 2012-03-31 | $0.01B | $0.05B | 21.69% |
| 2011-12-31 | $0.01B | $0.04B | 17.61% |
| 2011-09-30 | $0.01B | $0.04B | 17.95% |
| 2011-06-30 | $0.01B | $0.04B | 17.95% |
| 2011-03-31 | $0.01B | $0.04B | 15.48% |
| 2010-12-31 | $0.01B | $0.04B | 17.95% |
| 2010-09-30 | $0.01B | $0.04B | 17.95% |
| 2010-06-30 | $0.01B | $0.04B | 18.30% |
| 2010-03-31 | $0.01B | $0.04B | 21.33% |
| 2009-12-31 | $0.01B | $0.04B | 21.92% |
| 2009-09-30 | $0.01B | $0.04B | 22.38% |
| 2009-06-30 | $0.01B | $0.04B | 21.92% |
| 2009-03-31 | $0.01B | $0.04B | 21.33% |
| 2008-12-31 | $0.01B | $0.04B | 20.78% |
| 2008-09-30 | $0.01B | $0.04B | 20.25% |
| 2008-06-30 | $0.01B | $0.04B | 20.51% |
| 2008-03-31 | $0.01B | $0.04B | 20.92% |
| 2007-12-31 | $0.01B | $0.04B | 21.19% |
| 2007-09-30 | $0.01B | $0.04B | 21.62% |
| 2007-06-30 | $0.01B | $0.04B | 22.07% |
| 2007-03-31 | $0.01B | $0.04B | 22.54% |
| 2006-12-31 | $0.01B | $0.04B | 23.02% |
| 2006-09-30 | $0.01B | $0.04B | 23.53% |
| 2006-06-30 | $0.01B | $0.03B | 23.70% |
| 2006-03-31 | $0.01B | $0.03B | 23.70% |
| 2005-12-31 | $0.01B | $0.03B | 23.36% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.371B | $0.042B |
| Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvementsover existing clinical techniques. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $147.825B | 27.79 |
| Medtronic (MDT) | Ireland | $147.584B | 20.72 |
| Stryker (SYK) | United States | $82.482B | 28.52 |
| Boston Scientific (BSX) | United States | $59.759B | 28.99 |
| Baxter (BAX) | United States | $44.643B | 27.07 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $31.425B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $28.623B | 18.32 |
| Coloplast (CLPBY) | Denmark | $25.682B | 41.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $25.628B | 0.00 |
| Terumo (TRUMY) | Japan | $22.710B | 26.11 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $20.792B | 0.00 |
| ResMed (RMD) | United States | $19.048B | 36.32 |
| Sunny Optical Technology (SNPTF) | China | $16.288B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.082B | 54.05 |
| Canopy Growth (CGC) | Canada | $10.015B | 0.00 |
| Insulet (PODD) | United States | $8.923B | 528.71 |
| Perrigo (PRGO) | Ireland | $7.527B | 13.86 |
| William Demant Holdings (WILYY) | Denmark | $7.386B | 0.00 |
| Hill-Rom Holdings (HRC) | United States | $6.973B | 20.79 |
| Haemonetics (HAE) | United States | $6.488B | 48.96 |
| GN STORE NORD (GNNDY) | Denmark | $5.570B | 28.78 |
| Aurora Cannabis (ACB) | Canada | $5.377B | 0.00 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $4.296B | 0.00 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $4.192B | 0.00 |
| Neogen (NEOG) | United States | $4.086B | 67.83 |
| NuVasive (NUVA) | United States | $3.383B | 26.97 |
| ICU Medical (ICUI) | United States | $3.322B | 21.55 |
| Hutchison China MediTech (HCM) | China | $2.766B | 0.00 |
| Quidel (QDEL) | United States | $2.645B | 26.26 |
| Agios Pharmaceuticals (AGIO) | United States | $2.144B | 0.00 |
| National Vision Holdings (EYE) | United States | $2.086B | 45.03 |
| Cardiovascular Systems (CSII) | United States | $1.794B | 0.00 |
| Aphria (APHA) | $1.577B | 0.00 | |
| VAREX IMAGING (VREX) | United States | $1.099B | 25.32 |
| AtriCure (ATRC) | United States | $1.000B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.999B | 26.25 |
| Omeros (OMER) | United States | $0.912B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.882B | 14.34 |
| NanoString Technologies (NSTG) | United States | $0.807B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.793B | 20.22 |
| Cerus (CERS) | United States | $0.744B | 0.00 |
| PetIQ (PETQ) | United States | $0.740B | 17.47 |
| LeMaitre Vascular (LMAT) | United States | $0.710B | 42.09 |
| MacroGenics (MGNX) | United States | $0.631B | 0.00 |
| Surmodics (SRDX) | United States | $0.623B | 118.46 |
| TG Therapeutics (TGTX) | United States | $0.609B | 0.00 |
| Quanterix (QTRX) | United States | $0.598B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.463B | 21.43 |
| Meridian Bioscience (VIVO) | United States | $0.413B | 12.88 |
| BioLife Solutions (BLFS) | United States | $0.399B | 131.13 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.373B | 0.00 |
| Owens & Minor (OMI) | United States | $0.353B | 10.59 |
| Zynex (ZYXI) | United States | $0.304B | 32.28 |
| United Health Products (UEEC) | United States | $0.293B | 0.00 |
| Bovie Medical (APYX) | United States | $0.239B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.213B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.174B | 0.00 |
| Vapotherm (VAPO) | United States | $0.171B | 0.00 |
| Chimerix (CMRX) | United States | $0.146B | 0.00 |
| Fonar (FONR) | United States | $0.143B | 10.19 |
| Female Health (VERU) | United States | $0.124B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.120B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.102B | 0.00 |
| United-Guardian (UG) | United States | $0.088B | 20.88 |
| MRI Interventions (MRIC) | United States | $0.069B | 0.00 |
| Nephros (NEPH) | United States | $0.064B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.056B | 0.00 |
| Surface Oncology (SURF) | United States | $0.053B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.033B | 0.00 |
| Senestech (SNES) | United States | $0.026B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.023B | 0.00 |
| Myomo (MYO) | United States | $0.013B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.013B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.011B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.009B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.006B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.004B | 0.00 |
